Use of acellular cadaveric dermis and tissue expansion in postmastectomy breast reconstruction

The effect of incision choice on outcomes of nipple-sparing mastectomy reconstruction

“…These results are consistent with previous studies of acellular dermisassisted reconstruction following SSM (23,(26)(27)(28). Our results also demonstrate a trend toward larger breast size in breasts with nipple necrosis.…”

The Effect of Acellular Dermal Matrix in Implant-Based Immediate Breast Reconstruction with Latissimus Dorsi Flap.

“…FEBRUARY 2017 Recently, acellular dermal matrices have emerged as a potential modality for the prevention of capsular contracture. Their widespread use in breast reconstruction can be traced to several cited functional benefits over performing the conventional submuscular technique, such as better implant support and soft-tissue coverage, improved aesthetic results by better control and accentuation of the inframammary fold, definition of the lateral mammary contour, and lower pole projection for a more naturally ptotic contour of the reconstructed breast [6][7][8][9], decreased rippling and palpability along the inferior pole acting as camouflages the surface of the implant, reduced musculofascial dissection, and reduction in postoperative pain by obviating the need for the dissection of serratus anterior and rectus abdominis muscles [10].…”

Acellular Dermal Matrix for Optimizing Outcomes in Implant-Based Breast Reconstruction: Primary and Revisionary Procedures

“…More recently, ADMs have been used at the inferolateral pole after capsulotomy or capsulectomy to help correct and prevent capsular contracture (Breuing & Colwell, 2007;Hartzell et al, 2010;Spear et al, 2011). In ADM-assisted implant-based primary reconstructions, a low rate of capsular contracture (0%-2%) has been observed (S. Becker et al, 2009;Bindingnavele et al, 2007;Breuing & Colwell, 2007;Namnoum, 2009;Salzberg, 2006;Salzberg et al, 2011;Spear et al, 2008;Zienowicz & Karacaoglu, 2007), suggesting that ADMs may help prevent or reduce the risk of capsular contracture; hence, the rationale for using ADMs for the correction and prevention of capsular contracture. Animal and clinical studies suggest that ADMs may prevent capsular contracture by minimizing the inflammatory response, thereby reducing capsule formation around implants (Basu et al, 2010;Komorowska-Timek et al, 2009;Orenstein et al, 2010;Stump et al, 2009;Uzunismail et al, 2008).…”